Delving into the Latest Updates on vTvx Holdings II LLC with Synapse

The effect of HPP-A in the transplant model of psoriasis; in which a psoriatic lesion is induced in non-lesional skin transplanted onto immune-deficient (BNX) mice by injecting super-antigen activated peripheral blood cells intra-dermally into the transplant - The effect of HPP-A in the transplant model of psoriasis;

开始日期2013-02-01

申办/合作机构

vTvx Holdings II LLC

NCT01540864 / Terminated临床2期

A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects

The purpose of this study is to compare the safety and effect of HPP404 versus placebo on body weight in overweight or obese subjects.

开始日期2012-05-01

申办/合作机构

vTvx Holdings II LLC

NCT01524406 / Terminated临床1期

A Randomized, Double-blind, Placebo Controlled, Phase I Study to Evaluate the Safety and Tolerability of 28 Day Treatment With HPP593 Capsules in Healthy Volunteers During and After Limb Immobilization

This is a safety and tolerability study investigating the effect of HPP593 in healthy volunteers during and after limb immobilization.

开始日期2012-01-01

申办/合作机构

vTvx Holdings II LLC

100 项与 vTvx Holdings II LLC 相关的临床结果

登录后查看更多信息

0 项与 vTvx Holdings II LLC 相关的专利（医药）

登录后查看更多信息

100 项与 vTvx Holdings II LLC 相关的药物交易

登录后查看更多信息

100 项与 vTvx Holdings II LLC 相关的转化医学

登录后查看更多信息

组织架构

使用我们的机构树数据加速您的研究。

登录

或

查看完整样例数据

管线布局

2024年11月05日管线快照

管线布局中药物为当前组织机构及其子机构作为药物机构进行统计，早期临床1期并入临床1期，临床1/2期并入临床2期，临床2/3期并入临床3期

其他

4

登录后查看更多信息

当前项目

药物(靶点)	适应症	全球最高研发状态

Mavodelpar ( PPARδ )	肌肉萎缩更多	终止
HPP-404 ( H3 receptor )	肥胖更多	终止
TTP-854 ( BACE1 )	阿尔茨海默症更多	终止
HPP-376	疼痛更多	无进展